Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population
- PMID: 33511054
- PMCID: PMC7805290
- DOI: 10.2478/jtim-2020-0040
Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population
Abstract
Background and objective: Thrombophilia is a term used to define the conditions creating a tendency toward thrombosis. Factor V Leiden (FVL) is the most frequently observed genetic risk factor, and its frequency varies among societies and ethnicities. In this study, our aim is to identify the frequency of FVL mutation in patients with thrombosis, the frequency of FVL mutation for each thrombosis disease, whether there is any difference in the geographical distribution of FVL mutation in the Turkish population, correlation with age and gender, and correlation with arterial and venous thrombosis.
Methods: This is an observational case-control and retrospective study. Cases with the FVL mutation examination with clinical provisional diagnosis of arterial and/or venous thrombosis delivered and with the thrombosis proven by radiological visualization methods and laboratory examinations have been planned to be considered and assessed as cases with thrombosis.
Results: A total of 67 patients with thrombosis and 22 patients without thrombosis have been included within the study. Twenty-six of the cases with thrombosis were from the Black Sea region, 21 were from Eastern Anatolia, 12 were from Central Anatolia, 5 were from Marmara, and 3 were from Southeastern Anatolia. Eleven of the cases without thrombosis were from the Black Sea region, 1 was from Eastern Anatolia, 5 were from Central Anatolia, 2 were from Marmara, 1 was from Southeastern Anatolia, and 2 were from the Aegean region. The significance was resulted from the identification of thrombosis prevalence rate as significantly high in the Eastern Anatolian region.
Discussion: FVL mutation frequency is quite common in our country, and there are significant differences particularly in terms of regional distribution. Furthermore, FVL mutation is solely not the risk factor for thrombosis, and other coexisting genetic and acquired risk factors are substantial causes for the development of thrombosis.
Keywords: Factor V Leiden mutation; Turkish population; thrombophilia.
© 2020 Eray Yıldız, Funda Müşerref Türkmen, published by Sciendo.
Conflict of interest statement
Conflict of Interest None declared.
Similar articles
-
Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.Am J Hematol. 2001 Jun;67(2):107-11. doi: 10.1002/ajh.1087. Am J Hematol. 2001. PMID: 11343382
-
Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene "Mutation" (G20210A).Semin Thromb Hemost. 2019 Oct;45(7):730-742. doi: 10.1055/s-0039-1694772. Epub 2019 Aug 9. Semin Thromb Hemost. 2019. PMID: 31398733 Review.
-
Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?Thromb Haemost. 1997 Dec;78(6):1480-3. Thromb Haemost. 1997. PMID: 9423798
-
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.J Thromb Thrombolysis. 2013 Oct;36(3):324-31. doi: 10.1007/s11239-012-0824-5. J Thromb Thrombolysis. 2013. PMID: 23054468 Clinical Trial.
-
Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f. Genet Med. 2011. PMID: 21150787
Cited by
-
Impact of Thrombophilic Polymorphisms in Antenatal Women on Perinatal Health: A Single-Center Prospective Study.J Pers Med. 2024 Apr 19;14(4):433. doi: 10.3390/jpm14040433. J Pers Med. 2024. PMID: 38673060 Free PMC article.
-
Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways.J Transl Int Med. 2021 Dec 31;9(4):249-263. doi: 10.2478/jtim-2021-0046. eCollection 2021 Dec 1. J Transl Int Med. 2021. PMID: 35136724 Free PMC article.
-
Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations.Biology (Basel). 2025 Jul 1;14(7):800. doi: 10.3390/biology14070800. Biology (Basel). 2025. PMID: 40723359 Free PMC article. Review.
References
-
- Ozbek N, Factor V. G-A mutation distribution in a healthy Turkish population. Turk J Haematol 2009; 1691;26:9–11. - PubMed
-
- Linnemann B, Hart C. Laboratory Diagnostics in Thrombophilia. Hamostaseologie. 2019;39:49–61. - PubMed
-
- Singh D, Natarajan A, Nand S, Mai HP. Genetics of Hypercoagulable and Hypocoagulable States. Neurosurg Clin N Am. 2018;29:493–501. - PubMed
-
- Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost. 1999;81:733–8. - PubMed
-
- Pepe G, Rickards O, Vanegas OC, Brunelli T, Gori AM, Giusti B. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost. 1997;77:329–31. et al. - PubMed
LinkOut - more resources
Full Text Sources